Indegene Leverages Generative AI to Revolutionize Data Quality in Life Sciences

As life sciences organizations increasingly rely on AI for decision-making across commercial, medical, and research domains, the integrity of underlying data remains paramount. Indegene, a strategic partner to leading biopharma companies, has addressed the escalating challenge of managing enterprise data quality across fragmented platforms by deploying a generative AI-powered Data Quality Agent within its NEXT Unified Data Platform (NEXT UDP) on AWS.

Traditional data quality programs struggle with aligning technical and business rules due to their separation across codebases and business documentation. Static validation methods handle structural data checks but falter in capturing complex business logic and evolving domain-specific requirements. Maintaining, scaling, and governing these rules manually is labor-intensive and error-prone, hampering trust in data assets.

Indegene’s Data Quality Agent integrates multiple AI agents in a unified platform that consolidates commercial, clinical, and medical data into a governed environment. Powered by AWS services including Amazon Bedrock, Strands Agents, and AgentCore, the solution harnesses large language models (LLMs) alongside two complementary knowledge bases — an internal enterprise repository and an external reference framework — enabling context-aware data quality validation.

The agent automates the generation of both technical and business data quality rules by analyzing metadata, historical profiling, and anomaly detection results. Users select data sources and schemas, review AI-generated rule suggestions, and validate auto-generated SQL and Python code through a human-in-the-loop governance model. This approach allows for accelerated onboarding of datasets while preserving strict regulatory compliance and auditability.

Operational deployment of the AI Data Quality Agent has reduced the time to define and implement data quality rules by approximately 85%, enabling data teams to focus on rule review rather than manual creation. Enhanced anomaly detection and traceability foster earlier issue identification and increased confidence across commercial and medical analytics workflows.

Despite its advances, the system relies on continual input from subject matter experts to ensure business rule relevance and contextual accuracy. Data quality decisions incorporate confidence scoring, with critical rules requiring human approval to mitigate AI misclassification risks. The solution also benefits from AWS’s privacy, security, and compliance controls, crucial for sensitive healthcare data.

By embedding generative AI into data quality management at scale, Indegene’s platform exemplifies how large language models can transform enterprise data governance. This approach addresses the growing complexity of life sciences data ecosystems, supporting trusted, AI-ready data sets for improved operational outcomes and regulatory adherence.

As data volumes and complexity continue to deepen in life sciences, augmenting traditional manual validation with AI agents promises to enable continuous, scalable data quality capabilities tailored to industry-specific needs.